Compare Applied Materials, Inc. (AMAT) vs ResMed Inc. (RMD) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Applied Materials, Inc. vs ResMed Inc. — how do they compare? Applied Materials, Inc. trades at $550.91 (market cap $435.21B), while ResMed Inc. trades at $226 (market cap $32.78B). The key difference: Applied Materials, Inc. is far larger — about 13.3× ResMed Inc.'s market cap, and ResMed Inc. pays the higher dividend (1.17%). Which is the better fit depends on your goals.
| AMAT | RMD | |
|---|---|---|
Market Cap | $435.21B | $32.78B |
Sector | Technology | Health |
52-Week High | $723.00 | $293.73 |
52-Week Low | $156.25 | $182.82 |
Enterprise Value | $434.24B | $32.14B |
Dividend Yield | 0.39% | 1.17% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
AMAT trades at $525.61, up 0.67% in the last session, with a neutral technical signal and strong fundamentals. Recent earnings consistently beat expectations, with Q1 2026 EPS of $2.86 surpassing the $2.68 estimate. The stock benefits from robust profitability, including a 48.96% gross margin and 29.31% net margin, amid AI-driven semiconductor demand highlighted by CEO Gary Dickerson on CNBC on May 28, 2026.
Outlook remains positive with a consensus price target of $662.82, implying 26% upside, supported by 40 buy ratings and no sells. Risks include high valuation multiples like a P/E of 49.45 and cyclical semiconductor exposure, but growth in AI and data center investments offers significant opportunity.
ResMed (RMD) trades at $226.00, up 2.7% with strong technical momentum and bullish moving averages. The company delivered three consecutive quarterly EPS beats, with Q4 2026 revenue growing 9% to $1.5 billion and non-GAAP EPS rising 16% to $2.95. Fundamentals show robust profitability with 26.94% net margin and 24.27% ROE, though weak 2027 revenue guidance has tempered sentiment.
Outlook remains positive with analyst consensus target of $235 offering 4% upside, but risks include ventilator sales suspension and cost pressures. The stock's current valuation at 21.56 P/E appears reasonable given strong cash flow generation and consistent dividend payments, making it attractive for growth-oriented healthcare investors despite near-term guidance concerns.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Applied Materials, Inc.
Applied Materials is the world's largest supplier of semiconductor manufacturing equipment, providing materials engineering solutions to help make nearly every chip in the world. The firm's systems are used in nearly every major process step with the exception of lithography. Key tools include those for chemical and physical vapor deposition, etching, chemical mechanical polishing, wafer- and reticle-inspection, critical dimension measurement, and defect-inspection scanning electron microscopes.
Read more on AMAT →About ResMed Inc.
ResMed is one of the largest respiratory care device companies globally, primarily developing and supplying flow generators, masks and accessories for the treatment of sleep apnea. Increasing diagnosis of sleep apnea combined with ageing populations and increasing prevalence of obesity is resulting in a structurally growing market. The company earns roughly two thirds of its revenue in the Americas and the balance across other regions dominated by Europe, Japan and Australia. Recent developments and acquisitions have focused on digital health as ResMed is aiming to differentiate itself through the provision of clinical data for use by the patient, medical care advisor and payer in the out-of-hospital setting.
Read more on RMD →
